Mydecine Innovations Group Inc (MYCOF)
0.0061
0.00 (0.00%)
USD |
OTCM |
May 31, 16:00
Mydecine Innovations Group Enterprise Value: 4.357M for May 31, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 31, 2024 | 4.357M |
| May 30, 2024 | 4.472M |
| May 29, 2024 | 4.780M |
| May 28, 2024 | 4.604M |
| May 24, 2024 | 4.604M |
| May 23, 2024 | 4.604M |
| May 22, 2024 | 4.609M |
| May 21, 2024 | 4.361M |
| May 20, 2024 | 4.614M |
| May 17, 2024 | 4.804M |
| May 16, 2024 | 4.564M |
| May 15, 2024 | 4.707M |
| May 14, 2024 | 5.041M |
| May 13, 2024 | 4.627M |
| May 10, 2024 | 4.627M |
| May 09, 2024 | 4.315M |
| May 08, 2024 | 4.698M |
| May 07, 2024 | 4.620M |
| May 06, 2024 | 4.722M |
| May 03, 2024 | 4.625M |
| May 02, 2024 | 4.620M |
| May 01, 2024 | 4.809M |
| April 30, 2024 | 4.809M |
| April 29, 2024 | 4.809M |
| April 26, 2024 | 5.197M |
| Date | Value |
|---|---|
| April 25, 2024 | 4.709M |
| April 24, 2024 | 4.346M |
| April 23, 2024 | 4.609M |
| April 22, 2024 | 4.620M |
| April 19, 2024 | 4.693M |
| April 18, 2024 | 4.320M |
| April 17, 2024 | 4.320M |
| April 16, 2024 | 4.595M |
| April 15, 2024 | 4.940M |
| April 12, 2024 | 4.620M |
| April 11, 2024 | 5.032M |
| April 10, 2024 | 4.917M |
| April 09, 2024 | 4.917M |
| April 08, 2024 | 4.546M |
| April 05, 2024 | 4.835M |
| April 04, 2024 | 4.835M |
| April 03, 2024 | 4.804M |
| April 02, 2024 | 4.804M |
| April 01, 2024 | 4.804M |
| March 28, 2024 | 4.525M |
| March 27, 2024 | 4.793M |
| March 26, 2024 | 4.041M |
| March 25, 2024 | 4.604M |
| March 22, 2024 | 5.027M |
| March 21, 2024 | 5.113M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
1.190M
Minimum
Mar 18 2020
106.91M
Maximum
Jul 12 2021
23.76M
Average
9.383M
Median
Enterprise Value Benchmarks
| Rimrock Gold Corp | -- |
| InMed Pharmaceuticals Inc | -5.135M |
| Venus Concept Inc | 75.68M |
| Juva Life Inc | -- |
| Lucy Scientific Discovery Inc | 2.383M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -8.548M |
| Total Expenses (Quarterly) | 7.270M |
| EPS Diluted (Quarterly) | -1.170 |
| Earnings Yield | -25.36K% |
| Normalized Earnings Yield | -68409.11 |